Imprint's Technology and Expertise

Imprint Pharmaceuticals is developing entirely new and unique drug delivery technologies which have the potential to transform injectable therapies.

The successful delivery of injectable complex formulations is a fine balance between the requirements of the formulation, the manufacturing process and the injection device.  Any change in one impacts on the others, potentially increasing or decreasing the total dose that can be delivered.  Only by understanding the formulation, the manufacturing process and the injection device can the optimum delivery be achieved.  Imprint uniquely provides expertise in all three areas, enabling us to help you develop therapies that have improved clinical benefits. For example, using our technology to deliver a higher dose can enable the development of longer-acting therapies or reduce the force required to inject, thus enabling arthritic patients to inject easily. Both these advantages have substantial commercial value in their market.  By employing our expertise and technologies, you can transform the market potential of your products

• DepotOne is a '‘small'’ needle with high fluidic capacity designed to replace large needles
• Particulate injectors are designed to avoid blockages due to particulates
• The Imprinter is a device to treat recalcitrant skin diseases.
• Mixers/Solublisation devices: Devices to mix high concentrations pastes and solulise difficult therapies